Home > Market > Market Stats >  Glenmark Pharmaceuticals

Company Summary

GLENMARK PHARMACEUTICALS SUMMARY

Glenmark Pharmaceuticals is trading 4.00% lower at Rs 383.05 as compared to its last closing price. Glenmark Pharmaceuticals has been trading in the price range of 405.55 & 379.5. Glenmark Pharmaceuticals has given -5.96% in this year & -4.84% in the last 5 days.

 

Glenmark Pharmaceuticals has TTM P/E ratio 13.21 as compared to the sector P/E of 28.26. There are 17 analysts who have initiated coverage on Glenmark Pharmaceuticals. There are 2 analysts who have given it a strong buy rating & 8 analysts have given it a buy rating. 1 analysts have given the stock a sell rating.

 

The company posted a net profit of 260.44 Crores in its last quarter.

 

Listed peers of Glenmark Pharmaceuticals include Sanofi India (-0.49%), Suven Pharmaceuticals (0.15%), Glenmark Pharmaceuticals (-4%) etc.

 

Glenmark Pharmaceuticals has a 46.65% promoter holding & 53.35% public holding.

FAQs about Glenmark Pharmaceuticals

Glenmark Pharmaceuticals is trading at 383.05 as on 27 Jan, 2023 3:29:54 PM. This is -4.00% lower as compared to its previous closing price of 399
The market capitalization of Glenmark Pharmaceuticals is 11254.28 Cr as on 27 Jan, 2023 3:29:54 PM.
The average broker rating on Glenmark Pharmaceuticals is Buy. The breakup of analyst rating is given below -
  • 0 analysts have given a strong sell rating
  • 1 analysts have given a sell rating
  • 6 analysts have given a hold rating
  • 8 analysts have given a buy rating
  • 2 analysts have given a strong buy rating
The 52 wk high for Glenmark Pharmaceuticals is 512.7 whereas the 52 wk low is 348.9
Glenmark Pharmaceuticals can be analyzed on the following key metrics -
  • TTM P/E: 13.21
  • Sector P/E: 28.26
  • Dividend Yield: 0.63%
  • D/E ratio: -
Glenmark Pharmaceuticals reported a net profit of 941.71 Cr in 2022.

Recommended For You

Trending Stocks

×
Get alerts on WhatsApp
Set Preferences My ReadsWatchlistFeedbackRedeem a Gift CardLogout